Skip to main content
HR 1117 118th Congress House

Advancing Safe Medications for Moms and Babies Act of 2023

Official title: To implement certain recommendations to promote the inclusion of pregnant and lactating women in clinical research, and for other purposes.

Introduced: April 6, 2023 Introduced by: Castor, Kathy Democratic · Florida See on congress.gov
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 3, 2023
Referred to the Subcommittee on Health.
Feb 21, 2023
Referred to the House Committee on Energy and Commerce.
Feb 21, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action March 3, 2023

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Advancing Safe Medications for Moms and Babies Act of 2023

This bill establishes programs and requirements to support the inclusion of pregnant and lactating women in clinical research.

For example, the bill requires the Department of Health and Human Services to align the Food and Drug Administration's regulations for human subjects in clinical trials with other departmental regulations for pregnant women in clinical research.

The bill also establishes (1) a national online clearinghouse with information about clinical trials that enroll pregnant and lactating women, (2) an advisory committee to help coordinate federal activities with respect to clinical research for pregnant and lactating women, and (3) an educational campaign on the importance of including pregnant and lactating women in clinical research.

The National Institutes of Health must also prioritize certain research projects on new and existing medications for pregnant and lactating women based on need, feasibility, and the potential impact of the research.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1117: Advancing Safe Medications for Moms and Babies Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-HR-1117/
MLA
"H.R. 1117: Advancing Safe Medications for Moms and Babies Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-1117/.
Bluebook (legal)
H.R. 1117, 118th Cong. (2026), https://openamerica.io/bill/118-HR-1117/.
Markdown link
[H.R. 1117: Advancing Safe Medications for Moms and Babies Act of 2023](https://openamerica.io/bill/118-HR-1117/)
Report a problem